FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to medicine, namely to pharmaceuticals, and discloses a combination of aminocaproic acid and a copolymer of 2-methyl-5-vinylpyridine and N-vinylpyrrolidone, as well as a method for preventing influenza, ARVI. This combination is characterized in that it has an antiviral, immunomodulatory property, ratio of aminocaproic acid and copolymer of 2-methyl-5-vinylpyridine and N-vinylpyrrolidone is 1:0.5 wt. %.
EFFECT: antiviral and immunomodulating combination can be used for prevention of influenza and ARVI.
2 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF AMINOCAPROIC ACID-BASED SPRAY AND COPOLYMER OF 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE | 2017 |
|
RU2669811C1 |
| COMPLEX NASAL SPRAY BASED ON AMINOCAPROIC ACID AND A COPOLYMER OF 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE | 2017 |
|
RU2662089C1 |
| METHOD FOR QUANTITATIVE DETERMINATION OF AMINOCAPROIC ACID IN ITS SIMULTANEOUS PRESENCE WITH A COPOLYMER OF 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE BY THE METHOD OF HPLC | 2018 |
|
RU2700167C1 |
| COPOLYMER CONTAINING N-VINYL PYRROLIDONE, 2-METHYL-5-VINYL PYRIDINE AND 4-VINYL PYRIDINE LINKS | 2011 |
|
RU2459838C1 |
| N-VINYLPYRROLIDONE BASED COPOLYMERS | 2010 |
|
RU2415876C1 |
| COPOLYMERS OF 4-VINYLPYRIDINE OR 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE WITH TERMINAL CYANOVALERIC ACID RESIDUE AND USE THEREOF TO TREAT PNEUMOCONIOSIS | 2014 |
|
RU2550820C1 |
| INTERPOLYMER POLYELECTROLYTE COMPLEX AND A PROLONGED IMMUNOSTIMULATING AGENT ON ITS BASIS, FOR MEDICAL AND VETERINARY USE | 2017 |
|
RU2683947C1 |
| INFLUENZA VACCINE AND METHOD FOR PREPARING IT | 2010 |
|
RU2446824C2 |
| N-VINYLPYRROLIDONE-BASED COPOLYMERS IN FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS OF ACIDS | 2013 |
|
RU2533113C1 |
| INTERPOLYMER MATERIAL FOR MEDICAL AND VETERINARY USE AND PROLONGED MEDICINAL AND VETERINARY AGENTS ON ITS BASIS | 2017 |
|
RU2684608C1 |
